Skip to content

Screening Aid to Identify Corneas That May Have Pathologies or Other Conditions

Corneal Analysis - Pathology Detection Aid

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00396188
Enrollment
769
Registered
2006-11-06
Start date
2007-02-28
Completion date
2008-02-29
Last updated
2015-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal Diseases

Keywords

Keratoconus, LASIK, Orthokeratology, Pellucid Marginal Degeneration, Refractive Surgery, normal cornea, post myopic LASIK, post hyperopic LASIK, corneal pathologies (e.g. pellucid marginal degeneration)

Brief summary

The purpose of this study is to determine the ability of a proprietary software screening tool to discriminate normal corneas (front surface of the eye) from previously diagnosed corneal conditions (diseases/surgeries/pathologies) and to determine the repeatabiltity and reproducibility of the Atlas II corneal topographer in normal human corneas.

Detailed description

1. To establish reference values for SF, CIM, and TKM in subjects with normal corneas. 2. To establish reference values for SF, CIM, and TKM in subjects who underwent myopic laser vision correction. 3. To establish reference values for SF, CIM, and TKM in subjects who underwent hyperopic laser vision correction. 4. To establish reference values for SF, CIM, and TKM in subjects who were diagnosed to have keratoconus. 5. To establish reference values for SF, CIM, and TKM in subjects with history of orthokeratology. 6. To establish reference values for SF, CIM, and TKM in subjects with previously diagnosed corneal conditions (diseases/pathologies/surgeries) affecting the corneal surface that are not listed above. 7. To determine the repeatabiltity and reproducibility of the Atlas II corneal topographer in normal human corneas using true elevation data and axial curvature. 8. To determine the sensitivity, specificity, and accuracy of the Pathfinder II Corneal Analysis software in discriminating normal corneas from previously diagnosed corneal conditions (diseases/pathologies/surgeries) affecting the corneal surface (Phase II).

Interventions

None listed

Sponsors

Carl Zeiss Meditec, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Normals * Patients seeking initial laser vision correction that were screened to be good candidates for the procedure. * No history of refractive or other ocular surgery. * No corneal pathologies. * Normal corneal topography. * Contact lens wearers should discontinue use at least 2 weeks for hard contacts, and 3 days for soft lenses prior to imaging. Keratoconus * An irregular cornea determined by distorted keratometry mires, distortion of the retinoscopic, or ophthalmoscopic red reflex (or a combination of these) * At least one of the following biomicroscopic signs: Vogt's striae, Fleischer's ring of \>2 mm arc, or corneal scarring consistent with keratoconus. * Contact lens wearers should discontinue use preferably 1 day or at least half an hour prior to imaging. Myopic Laser Vision Correction Patients who have undergone myopic: * LASIK * PRK * LASEK Hyperopic Laser Vision Correction Patients who have undergone hyperopic: * LASIK * PRK * LASEK Orthokeratology * Patients using specially designed rigid contact lenses to reshape the cornea to temporarily reduce or eliminate refractive error. * Subjects must be 18 years of age or older; able and willing to make the required visit; and able and willing to give consent.

Exclusion criteria

* Patients that underwent corneal transplantation or any ocular surgery for the following categories: normal, keratoconus, and orthokeratology) * Any active infection or inflammation of the cornea. * PI decides that subject is not suitable due to medical risk.

Design outcomes

Primary

MeasureTime frame
Reference values of normal and previously diagnosed corneal conditions by Atlas II corneal topographer1-2 hours

Secondary

MeasureTime frame
Repeatabiltity and reproducibility of the Atlas II corneal topographer in human corneas1-2 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026